The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Circadian Timing of Cancer Chemotherapy
Abstract
Animal studies have indicated that the time of administration of adriamycin and cisplatin, two widely used anticancer drugs, has a profound effect on their toxicity. This effect in cancer chemotherapy was studied in 31 patients with advanced ovarian cancer. Patients received at least eight monthly courses of adriamycin that were followed 12 hours later by cisplatin, with adriamycin randomly administered at either 6 a.m. or 6 p.m. The results show that in the group receiving adriamycin in the evening and cisplatin in the morning (i) twice as many patients required reductions in dosage and delays in treatment, (ii) four times as many treatments had to be delayed, (iii) drug dosages had to be modified downward three times as often, and (iv) even with more dose attenuation and treatment delays, treatment complications were still about two times more common as in the group receiving adriamycin in the morning and cisplatin in the evening. These findings show that the circadian stage at which anticancer drugs are given to patients should be carefully considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Hryniuk, W., & Bush, H. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.11.1281 · Cited by 885
Haus, E., Halberg, F., Scheving, L. E., Pauly, J. E., Cardoso, S., Kühl, J. F. W., Sothern, R. B., Shiotsuka, R. N., & Hwang, D. S. (1972) · Science · doi:10.1126/science.177.4043.80 · Cited by 162
Quo vadis basic and clinical chronobiology: Promise for health maintenance
Franz Halberg, A. (1983) · American Journal of Anatomy · doi:10.1002/aja.1001680408 · Cited by 141
Endmund, L. (1988) · Springer eBooks · doi:10.1007/978-1-4612-3742-6_3 · Cited by 108
Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats.
Hrushesky, W. J. M., Lévi, F. A., Halberg, F., et al. (1982) · PubMed · Cited by 76
Self-citationCircadian time dependence of cisplatin urinary kinetics
Hrushesky, W. J. M., Borch, R. F., & Lévi, F. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.168 · Cited by 62
Self-citationLévi, F., Hrushesky, W. J. M., Franz Halberg, A., Langevin, T., Haus, E. L., & Kennedy, B. J. (1982) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(82)90116-x · Cited by 54
Self-citation
Cited by
Procedures for numerical analysis of circadian rhythms
Refinetti, R., Cornélissen, G., & Halberg, F. (2007) · Biological Rhythm Research · doi:10.1080/09291010600903692 · Cited by 726
Toxicity of platinum compounds
Hartmann, J. T., & Lipp, H.-P. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.889 · Cited by 604
Clinical Pharmacokinetics of Doxorubicin
Speth, P. A. J., van Hoesel, Q. G. C. M., & Haanen, C. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815010-00002 · Cited by 420
New Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
Biological Rhythm and Chronotype: New Perspectives in Health
Montaruli, A., Castelli, L., Mulè, A., Scurati, R., Esposito, F., Galasso, L., & Roveda, E. (2021) · Biomolecules · doi:10.3390/biom11040487 · Cited by 360
Metadata
- Authors
- Hrushesky, W. J. M.
- Venue
- Science
- Published
- 1985-04-05
- Volume
- 228
- Issue
- 4695
- Pages
- 73-75
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2084699449
- Cited by
- 370
- References
- 7
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circadian Timing of Cancer Chemotherapy. https://app.cochat.ai/papers/10.1126/science.3883493
- The paper
- Hrushesky, W. J. M. (1985). Circadian Timing of Cancer Chemotherapy. Science. https://doi.org/10.1126/science.3883493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.